Significant Increase in Risk of Fibrosis or Cirrhosis at Time of HCV Diagnosis for Hispanics With Diabetes and Obesity Compared With Other Ethnic Groups

Barbara J. Turner, Chen Pin Wang, Trisha V. Melhado, Raudel Bobadilla, Mamta Jain, Amit Singal

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background & Aims: Advanced liver disease, which includes fibrosis and cirrhosis, has been reported to be more prevalent in Hispanics patients at the time of diagnosis of chronic hepatitis C virus (HCV) infection than non-Hispanic black or non-Hispanic white patients. We performed a propensity score-matched analysis to determine whether metabolic risk factors contribute to this disparity. Methods: We collected data from persons with 748 HCV infection (22% Hispanic, 53% non-Hispanic black, and 26% non-Hispanic white; 23% with advanced liver disease), born from 1945 through 1965, diagnosed at 6 health care systems in Texas. Advanced liver disease was defined as a FIB-4 index score above 3.25. We examined the association between advanced liver disease and race or ethnicity, metabolic risk (based on diabetes mellitus and body mass index [BMI]) and heavy alcohol use in propensity score-matched analyses. Results: In propensity-score matched models, among those who were obese (BMI ≥30) with a diagnosis of diabetes, the adjusted odds ratio of advanced liver disease for Hispanics vs non-Hispanic black was 7.89 (95% CI, 3.66–17.01) and adjusted odds ratio = 12.49 (95% CI, 3.24–48.18) for Hispanic vs non-Hispanic white patients (both P <.001). Conclusions: HCV-infected Hispanics with obesity and diabetes have a far higher risk for advanced liver disease than other racial or ethnic groups. These findings highlight the need for HCV treatment and management of probable concurrent fatty liver disease. Even after we accounted for metabolic risk factors, Hispanics were still at higher risk for advanced liver disease, indicating the potential involvement of other factors such as genetic variants.

Original languageEnglish (US)
JournalClinical Gastroenterology and Hepatology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Hispanic Americans
Ethnic Groups
Hepacivirus
Liver Diseases
Fibrosis
Obesity
Propensity Score
Virus Diseases
Body Mass Index
Odds Ratio
Chronic Hepatitis C
Fatty Liver
Diabetes Mellitus
Alcohols
Delivery of Health Care

Keywords

  • Advanced Liver Disease
  • Chronic Hepatitis C
  • Health Disparity
  • Metabolic Syndrome

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Significant Increase in Risk of Fibrosis or Cirrhosis at Time of HCV Diagnosis for Hispanics With Diabetes and Obesity Compared With Other Ethnic Groups. / Turner, Barbara J.; Wang, Chen Pin; Melhado, Trisha V.; Bobadilla, Raudel; Jain, Mamta; Singal, Amit.

In: Clinical Gastroenterology and Hepatology, 01.01.2019.

Research output: Contribution to journalArticle

@article{d2f3e35fb3774018958f1cfebd3bbca3,
title = "Significant Increase in Risk of Fibrosis or Cirrhosis at Time of HCV Diagnosis for Hispanics With Diabetes and Obesity Compared With Other Ethnic Groups",
abstract = "Background & Aims: Advanced liver disease, which includes fibrosis and cirrhosis, has been reported to be more prevalent in Hispanics patients at the time of diagnosis of chronic hepatitis C virus (HCV) infection than non-Hispanic black or non-Hispanic white patients. We performed a propensity score-matched analysis to determine whether metabolic risk factors contribute to this disparity. Methods: We collected data from persons with 748 HCV infection (22{\%} Hispanic, 53{\%} non-Hispanic black, and 26{\%} non-Hispanic white; 23{\%} with advanced liver disease), born from 1945 through 1965, diagnosed at 6 health care systems in Texas. Advanced liver disease was defined as a FIB-4 index score above 3.25. We examined the association between advanced liver disease and race or ethnicity, metabolic risk (based on diabetes mellitus and body mass index [BMI]) and heavy alcohol use in propensity score-matched analyses. Results: In propensity-score matched models, among those who were obese (BMI ≥30) with a diagnosis of diabetes, the adjusted odds ratio of advanced liver disease for Hispanics vs non-Hispanic black was 7.89 (95{\%} CI, 3.66–17.01) and adjusted odds ratio = 12.49 (95{\%} CI, 3.24–48.18) for Hispanic vs non-Hispanic white patients (both P <.001). Conclusions: HCV-infected Hispanics with obesity and diabetes have a far higher risk for advanced liver disease than other racial or ethnic groups. These findings highlight the need for HCV treatment and management of probable concurrent fatty liver disease. Even after we accounted for metabolic risk factors, Hispanics were still at higher risk for advanced liver disease, indicating the potential involvement of other factors such as genetic variants.",
keywords = "Advanced Liver Disease, Chronic Hepatitis C, Health Disparity, Metabolic Syndrome",
author = "Turner, {Barbara J.} and Wang, {Chen Pin} and Melhado, {Trisha V.} and Raudel Bobadilla and Mamta Jain and Amit Singal",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.cgh.2018.11.059",
language = "English (US)",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Significant Increase in Risk of Fibrosis or Cirrhosis at Time of HCV Diagnosis for Hispanics With Diabetes and Obesity Compared With Other Ethnic Groups

AU - Turner, Barbara J.

AU - Wang, Chen Pin

AU - Melhado, Trisha V.

AU - Bobadilla, Raudel

AU - Jain, Mamta

AU - Singal, Amit

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background & Aims: Advanced liver disease, which includes fibrosis and cirrhosis, has been reported to be more prevalent in Hispanics patients at the time of diagnosis of chronic hepatitis C virus (HCV) infection than non-Hispanic black or non-Hispanic white patients. We performed a propensity score-matched analysis to determine whether metabolic risk factors contribute to this disparity. Methods: We collected data from persons with 748 HCV infection (22% Hispanic, 53% non-Hispanic black, and 26% non-Hispanic white; 23% with advanced liver disease), born from 1945 through 1965, diagnosed at 6 health care systems in Texas. Advanced liver disease was defined as a FIB-4 index score above 3.25. We examined the association between advanced liver disease and race or ethnicity, metabolic risk (based on diabetes mellitus and body mass index [BMI]) and heavy alcohol use in propensity score-matched analyses. Results: In propensity-score matched models, among those who were obese (BMI ≥30) with a diagnosis of diabetes, the adjusted odds ratio of advanced liver disease for Hispanics vs non-Hispanic black was 7.89 (95% CI, 3.66–17.01) and adjusted odds ratio = 12.49 (95% CI, 3.24–48.18) for Hispanic vs non-Hispanic white patients (both P <.001). Conclusions: HCV-infected Hispanics with obesity and diabetes have a far higher risk for advanced liver disease than other racial or ethnic groups. These findings highlight the need for HCV treatment and management of probable concurrent fatty liver disease. Even after we accounted for metabolic risk factors, Hispanics were still at higher risk for advanced liver disease, indicating the potential involvement of other factors such as genetic variants.

AB - Background & Aims: Advanced liver disease, which includes fibrosis and cirrhosis, has been reported to be more prevalent in Hispanics patients at the time of diagnosis of chronic hepatitis C virus (HCV) infection than non-Hispanic black or non-Hispanic white patients. We performed a propensity score-matched analysis to determine whether metabolic risk factors contribute to this disparity. Methods: We collected data from persons with 748 HCV infection (22% Hispanic, 53% non-Hispanic black, and 26% non-Hispanic white; 23% with advanced liver disease), born from 1945 through 1965, diagnosed at 6 health care systems in Texas. Advanced liver disease was defined as a FIB-4 index score above 3.25. We examined the association between advanced liver disease and race or ethnicity, metabolic risk (based on diabetes mellitus and body mass index [BMI]) and heavy alcohol use in propensity score-matched analyses. Results: In propensity-score matched models, among those who were obese (BMI ≥30) with a diagnosis of diabetes, the adjusted odds ratio of advanced liver disease for Hispanics vs non-Hispanic black was 7.89 (95% CI, 3.66–17.01) and adjusted odds ratio = 12.49 (95% CI, 3.24–48.18) for Hispanic vs non-Hispanic white patients (both P <.001). Conclusions: HCV-infected Hispanics with obesity and diabetes have a far higher risk for advanced liver disease than other racial or ethnic groups. These findings highlight the need for HCV treatment and management of probable concurrent fatty liver disease. Even after we accounted for metabolic risk factors, Hispanics were still at higher risk for advanced liver disease, indicating the potential involvement of other factors such as genetic variants.

KW - Advanced Liver Disease

KW - Chronic Hepatitis C

KW - Health Disparity

KW - Metabolic Syndrome

UR - http://www.scopus.com/inward/record.url?scp=85064329178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064329178&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2018.11.059

DO - 10.1016/j.cgh.2018.11.059

M3 - Article

C2 - 30529733

AN - SCOPUS:85064329178

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

ER -